METASTATIC BREAST CANCER (HR+/ HER2-)

Clinical trials for METASTATIC BREAST CANCER (HR+/ HER2-) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC BREAST CANCER (HR+/ HER2-) trials appear

Sign up with your email to follow new studies for METASTATIC BREAST CANCER (HR+/ HER2-), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Pfizer tests new pill to fight advanced cancers

Disease control Recruiting now

This early-stage study is testing a new oral medication called PF-08032562, both alone and in combination with other cancer drugs, for people with advanced or metastatic breast or colorectal cancer. The main goals are to find a safe dose and see how the body processes the drug. R…

Matched conditions: METASTATIC BREAST CANCER (HR+/ HER2-)

Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

METASTATIC BREAST CANCER (HR+/ HER2-)

Get alerted when new METASTATIC BREAST CANCER (HR+/ HER2-) trials appear

Pfizer tests new pill to fight advanced cancers